Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals-Reference-Cited by-同舟云学术

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

Published:2017-01 Issue:1 Volume:8 Page:179-187
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Fandos Noelia¹,Pérez‐Grijalba Virginia¹,Pesini Pedro¹,Olmos Salvador²,Bossa Matías²,Villemagne Victor L.³,Doecke James⁴,Fowler Christopher³,Masters Colin L.³,Sarasa Manuel¹,

Affiliation:

1. R&D DepartmentAraclon Biotech Ltd.ZaragozaSpain

2. Aragon Institute of Engineering Research, University of ZaragozaZaragozaSpain

3. The Florey Institute of Neuroscience and Mental Health, University of MelbourneParkvilleVictoriaAustralia

4. CSIRO Health and Biosecurity/Australian E‐Health Research CentreBrisbaneQueenslandAustralia

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2017.07.004

Reference49 articles.